Pay in 4 interest-free payments of $7.02 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Decapeptyl: EUR 536M Key Peptide Products: Lanreotide (Somatuline somatostatin analogue for NETs, acromegaly), triptorelin (Decapeptyl GnRH agonist for prostate/breast cancer, endometriosis), abarelix (predecessor), cabozantinib (Cabometyx kinase inhibitor) Therapeutic Segments: Oncology (NETs, prostate cancer, breast cancer)
Researchers have described this as the compounds key differentiating feature in systematic reviews of the preclinical literature
Seek medical attention for severe, persistent headaches not relieved by typical interventions
Data on appropriate dosing and studies involving pediatric cancer patients remain limited
snagged a potential drug in the burgeoning market for obesity medications in a deal worth as much as $2 billion
For patients in the DFW area weighing all options, our team at BodEvolve Bariatric often sees Rybelsus come up in conversations alongside surgical and non-surgical paths
